BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kontoghiorghe CN, Kontoghiorghes GJ. New developments and controversies in iron metabolism and iron chelation therapy. World J Methodol 2016; 6(1): 1-19 [PMID: 27019793 DOI: 10.5662/wjm.v6.i1.1] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Wu Y, Liu J, Shao M, Zhang P, Song S, Yang G, Liu X, Liu Z. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents. Journal of Inorganic Biochemistry 2022;233:111855. [DOI: 10.1016/j.jinorgbio.2022.111855] [Reference Citation Analysis]
2 Entezari S, Haghi SM, Norouzkhani N, Sahebnazar B, Vosoughian F, Akbarzadeh D, Islampanah M, Naghsh N, Abbasalizadeh M, Deravi N, Abd Elhakim Y. Iron Chelators in Treatment of Iron Overload. Journal of Toxicology 2022;2022:1-18. [DOI: 10.1155/2022/4911205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Peng Y, Chang X, Lang M. Iron Homeostasis Disorder and Alzheimer's Disease. Int J Mol Sci 2021;22:12442. [PMID: 34830326 DOI: 10.3390/ijms222212442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Silva FT, Espósito BP. Intracellular Iron Binding and Antioxidant Activity of Phytochelators. Biol Trace Elem Res 2021. [PMID: 34648123 DOI: 10.1007/s12011-021-02965-y] [Reference Citation Analysis]
5 Kontoghiorghes GJ. Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs. Medicines (Basel) 2021;8:36. [PMID: 34357152 DOI: 10.3390/medicines8070036] [Reference Citation Analysis]
6 Md Yusop AH, Al Sakkaf A, Nur H. Modifications on porous absorbable Fe-based scaffolds for bone applications: A review from corrosion and biocompatibility viewpoints. J Biomed Mater Res B Appl Biomater 2021. [PMID: 34132457 DOI: 10.1002/jbm.b.34893] [Reference Citation Analysis]
7 Lu Y, Ruan G, Du W, Li J, Yang N, Wu Q, Lu L, Zhang C, Li L. Recent progress in rational design of fluorescent probes for Fe2+ and bioapplication. Dyes and Pigments 2021;190:109337. [DOI: 10.1016/j.dyepig.2021.109337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kontoghiorghes GJ, Kolnagou A, Demetriou T, Neocleous M, Kontoghiorghe CN. New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications. Int J Mol Sci 2021;22:5546. [PMID: 34074010 DOI: 10.3390/ijms22115546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zheng X, Wang X, Ding Z, Li W, Peng Y, Zheng J. Metabolic Activation of Deferiprone Mediated by CYP2A6. Xenobiotica 2021;:1-33. [PMID: 34006188 DOI: 10.1080/00498254.2021.1931729] [Reference Citation Analysis]
10 Ma L, Gholam Azad M, Dharmasivam M, Richardson V, Quinn RJ, Feng Y, Pountney DL, Tonissen KF, Mellick GD, Yanatori I, Richardson DR. Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol 2021;41:101896. [PMID: 33799121 DOI: 10.1016/j.redox.2021.101896] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Sullivan KE, Mylniczenko ND, Nelson SE Jr, Coffin B, Lavin SR. Practical Management of Iron Overload Disorder (IOD) in Black Rhinoceros (BR; Diceros bicornis). Animals (Basel) 2020;10:E1991. [PMID: 33138144 DOI: 10.3390/ani10111991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kontoghiorghes GJ, Kontoghiorghe CN. Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells 2020;9:E1456. [PMID: 32545424 DOI: 10.3390/cells9061456] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
13 Kaviani S, Izadyar M, Housaindokht MR. A DFT study on the metal ion selectivity of deferiprone complexes. Comput Biol Chem 2020;86:107267. [PMID: 32470911 DOI: 10.1016/j.compbiolchem.2020.107267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Fakharzadeh S, Argani H, Dadashzadeh S, Kalanaky S, Mohammadi Torbati P, Nazaran MH, Basiri A. BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease. Diabetes Metab Syndr Obes 2020;13:1179-88. [PMID: 32368111 DOI: 10.2147/DMSO.S240757] [Reference Citation Analysis]
15 Kontoghiorghes GJ, Kleanthous M, Kontoghiorghe CN. The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia. Mediterr J Hematol Infect Dis 2020;12:e2020011. [PMID: 31934321 DOI: 10.4084/MJHID.2020.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wahidiyat PA, Wijaya E, Soedjatmiko S, Timan IS, Berdoukas V, Yosia M. Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major. Blood Cells, Molecules, and Diseases 2019;77:67-71. [DOI: 10.1016/j.bcmd.2019.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Deng M, Liao C, Wang X, Chen S, Qi F, Zhao X, Yu P. A paper-based colorimetric microfluidic sensor fabricated by a novel spray painting prototyping process for iron analysis. Can J Chem 2019;97:373-7. [DOI: 10.1139/cjc-2018-0346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Osborne V, Davies M, Layton D, Shakir SAW. Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England. Drug Saf 2018;41:267-75. [PMID: 29019038 DOI: 10.1007/s40264-017-0606-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Badu-Boateng C, Naftalin RJ. Ascorbate and ferritin interactions: Consequences for iron release in vitro and in vivo and implications for inflammation. Free Radic Biol Med 2019;133:75-87. [PMID: 30268889 DOI: 10.1016/j.freeradbiomed.2018.09.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
20 Rao SS, Adlard PA. Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration. Front Mol Neurosci 2018;11:276. [PMID: 30174587 DOI: 10.3389/fnmol.2018.00276] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
21 Cappellini MD, Porter JB, Viprakasit V, Taher AT. A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? Blood Reviews 2018;32:300-11. [DOI: 10.1016/j.blre.2018.02.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 11.0] [Reference Citation Analysis]
22 Özbolat G, Yegani AA, Tuli A. Synthesis, characterization and electrochemistry studies of iron(III) complex with curcumin ligand. Clin Exp Pharmacol Physiol 2018;45:1221-6. [DOI: 10.1111/1440-1681.12964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Ozdemir M, Zhang Y, Guo M. A highly selective “off-on” fluorescent sensor for subcellular visualization of labile iron(III) in living cells. Inorganic Chemistry Communications 2018;90:73-7. [DOI: 10.1016/j.inoche.2018.02.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Taher AT, Porter JB, Kattamis A, Viprakasit V, Cappellini MD. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes. Drug Des Devel Ther 2016;10:4073-8. [PMID: 28008230 DOI: 10.2147/DDDT.S117080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Eid R, Arab NT, Greenwood MT. Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms. Biochim Biophys Acta Mol Cell Res 2017;1864:399-430. [PMID: 27939167 DOI: 10.1016/j.bbamcr.2016.12.002] [Cited by in Crossref: 106] [Cited by in F6Publishing: 90] [Article Influence: 17.7] [Reference Citation Analysis]